UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000016016
Receipt number R000018618
Scientific Title A randomized controlled trial for the effectiveness of self-management education using structured self-monitoring of blood glucose in noninsulin-treated type 2 diabetes patients
Date of disclosure of the study information 2014/12/22
Last modified on 2017/06/22 17:47:29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A randomized controlled trial for the effectiveness of self-management education using structured self-monitoring of blood glucose in noninsulin-treated type 2 diabetes patients

Acronym

Effectiveness of structured self-monitoring of blood glucose in noninsulin-treated type 2 diabetes patients(RCT)

Scientific Title

A randomized controlled trial for the effectiveness of self-management education using structured self-monitoring of blood glucose in noninsulin-treated type 2 diabetes patients

Scientific Title:Acronym

Effectiveness of structured self-monitoring of blood glucose in noninsulin-treated type 2 diabetes patients(RCT)

Region

Japan


Condition

Condition

Type 2 diabetes

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effectiveness of self-management education using structured self-monitoring of blood glucose in noninsulin-treated type 2 diabetes patients

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Change in HbA1c (after 6 months and 12 months from starting SMBG use)

Key secondary outcomes

1.Self-efficacy for health behavior
2.health and life habit
3.health literacy
(after 6 months and 12 months from starting SMBG use)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is considered as a block.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Device,equipment

Interventions/Control_1

1.7-point SMBG(fasting, preprandial/2-h postprandial at meal time, bed time) on 3 consecutive days every two months and recording
2.Comments to results of SMBG from physicians and nurses in outpatient clinic

Interventions/Control_2

Usual diabetes self-management education

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

25 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.type 2 diabetes> 1 years
2.HbA1c level 7-12%(NGSP)
3.Noninsulin treatment and nonincretin injection treatment
4.not routine use of SMBG
5.currently treated by diet, exercise, oral diabetes medication
6.able to complete self-reported questionnaires

Key exclusion criteria

1. type 1 diabetes
2. currently treated by dementia, psychosis, recent emotional trauma
3. used steroids more than 14 days within the last 3 months
4. treated with chemotherapy or radiation therapy
5. pregnant or breast feeding
6. had severe depression or other severe psychological conditions

Target sample size

150


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Mariko Shiramizu

Organization

Kanagawa University of Human Services

Division name

School of Nursing, Faculty of Health & Social Services

Zip code


Address

1-10-1, Heisei-cho, Yokosuka, Kanagawa

TEL

046-828-2624

Email

shiramizu-m@kuhs.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Mariko Shiramizu

Organization

Kanagawa University of Human Services

Division name

School of Nursing, Faculty of Health & Social Services

Zip code


Address

1-10-1, Heisei-cho, Yokosuka, Kanagawa

TEL

046-828-2624

Homepage URL


Email

shiramizu-m@kuhs.ac.jp


Sponsor or person

Institute

Faculty of Health & Social Services, Kanagawa University of Human Services

Institute

Department

Personal name



Funding Source

Organization

Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

済生会横浜市南部病院(神奈川県)、川崎市立川崎病院(神奈川県)、川崎市立井田病院(神奈川県)


Other administrative information

Date of disclosure of the study information

2014 Year 12 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

This was a randomized controlled study to assess the effectiveness of structured self-monitoring of blood glucose testing among noninsulin-treated type 2 diabetes patients. Patients were recruited and randomized to a control group (CG) with usual care or a structured testing group (STG) at least every other month use of structured self-monitoring of blood glucose (SMBG). STG patients were trained to use a paper tool to collect 7-point glucose profiles over 3 consecutive days. The primary end point was HbA1c level measured at 6 months. The 6-month median HbA1c (IQR) of STG group was 7.2% and that of CG group was 7.6%; there was no statistically significant deference between them. Only the STG group showed significant reductions of median HbA1c from 7.5% to 7.2%.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 09 Month 24 Day

Date of IRB


Anticipated trial start date

2014 Year 12 Month 25 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 12 Month 20 Day

Last modified on

2017 Year 06 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018618


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name